KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Other financing activities (2021 - 2024)

Historic Other financing activities for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Q3 2024 value amounting to -$4000.0.

  • Ginkgo Bioworks Holdings' Other financing activities fell 30000.0% to -$4000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.6 million, marking a year-over-year increase of 9020.31%. This contributed to the annual value of $59.9 million for FY2021, which is N/A changed from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Other financing activities of -$4000.0 as of Q3 2024, which was down 30000.0% from $604000.0 recorded in Q4 2023.
  • Ginkgo Bioworks Holdings' Other financing activities' 5-year high stood at $34.1 million during Q3 2021, with a 5-year trough of -$88000.0 in Q3 2022.
  • Over the past 4 years, Ginkgo Bioworks Holdings' median Other financing activities value was $301500.0 (recorded in 2023), while the average stood at $7.7 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Other financing activities surged by 158208.96% in 2022, and later plummeted by 30000.0% in 2024.
  • Ginkgo Bioworks Holdings' Other financing activities (Quarter) stood at -$67000.0 in 2021, then skyrocketed by 1582.09% to $993000.0 in 2022, then crashed by 39.17% to $604000.0 in 2023, then tumbled by 100.66% to -$4000.0 in 2024.
  • Its Other financing activities was -$4000.0 in Q3 2024, compared to $604000.0 in Q4 2023 and -$1000.0 in Q3 2023.